{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:49:20Z","timestamp":1792043360127,"version":"4.4.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"DOI":"10.1186\/s12969-026-01238-z","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:37:21Z","timestamp":1791920241000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["African recommendations for diagnosis and management of systemic juvenile idiopathic arthritis (sJIA) \u2013 a PAFLAR initiative"],"prefix":"10.1186","volume":"24","author":[{"given":"Soad","family":"Hashad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1146-7963","authenticated-orcid":false,"given":"Angela Nyangore","family":"Migowa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Seri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ourida","family":"Gacem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Sobh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hala","family":"Etayari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman A.","family":"Almsillati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Ravelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Quartier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayodele","family":"Faleye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doaa","family":"Mosad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Palalane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Temesgen","family":"Teferi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaninga Halwani","family":"Fuseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Lishan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wassila","family":"Messadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"Ngandeu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yassmin","family":"Taha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wafa","family":"Hamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samah","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanane Lassoued","family":"Ferjani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chafia Makhloufi","family":"Dahou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmine","family":"Makhlouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samy","family":"Slimani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiaan","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djohra","family":"Hadef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,13]]},"reference":[{"key":"1238_CR1","first-page":"2138","volume-title":"Juvenile idiopathic arthritis","author":"B Prakken","year":"2011","unstructured":"Prakken B, Albani S, Martini A. Juvenile idiopathic arthritis. Vol. 377. Lancet. Elsevier B.V; 2011. p. 2138\u201349."},{"issue":"9563","key":"1238_CR2","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/S0140-6736(07)60363-8","volume":"369","author":"A Ravelli","year":"2007","unstructured":"Ravelli A, Martini A. Juvenile idiopathic arthritis [Internet]. vol. Lancet. 2007. Available from: 369(9563):767\u201378. https:\/\/doi.org\/10.1016\/S0140-6736(07)60363-8. www.thelancet.com.","journal-title":"Lancet"},{"issue":"2","key":"1238_CR3","doi-asserted-by":"publisher","first-page":"90","DOI":"10.4274\/balkanmedj.2017.0111","volume":"34","author":"K Barut","year":"2017","unstructured":"Barut K, Adrovic A, \u015eahin S, Kasap\u00e7opur \u00d6. Juvenile idiopathic arthritis. Balkan Med J. 2017;34(2):90\u2013101. https:\/\/doi.org\/10.4274\/balkanmedj.2017.0111.","journal-title":"Balkan Med J"},{"issue":"9","key":"1238_CR4","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1136\/ard.2004.023697","volume":"63","author":"M Dougados","year":"2004","unstructured":"Dougados M, Betteridge N, Burmester GR, Euller-Ziegler L, Guillemin F, Hirvonen JLloyd J, et al. EULAR standardised operating procedures for the elaboration, evaluation, dissemination, and implementation of recommendations endorsed by the EULAR standing committees. Ann Rheumatic Dis. 2004, Sep;63(9):1172\u201376. https:\/\/doi.org\/10.1136\/ard.2004.023697.","journal-title":"Ann Rheumatic Dis"},{"issue":"1","key":"1238_CR5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1136\/annrheumdis-2014-206350","volume":"74","author":"D Van Der Heijde","year":"2015","unstructured":"Van Der Heijde D, Aletaha D, Carmona L, Edwards CJ, Kvien TK, Kouloumas M, et al. 2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations. Ann Rheumatic Dis. 2015;74(1):8\u201313. https:\/\/doi.org\/10.1136\/annrheumdis-2014-206350. 2015 Jan 1.","journal-title":"Ann Rheumatic Dis"},{"issue":"4","key":"1238_CR6","doi-asserted-by":"publisher","first-page":"769","DOI":"10.4236\/ojped.2020.104078","volume":"10","author":"AR Albaker","year":"2020","unstructured":"Albaker AR. Current review of systemic juvenile idiopathic arthritis: what Do Paediatricians need to know? Ojped. 2020;10(4):769\u2013801. https:\/\/doi.org\/10.4236\/ojped.2020.104078.","journal-title":"Ojped"},{"key":"1238_CR7","doi-asserted-by":"publisher","unstructured":"Hinze CH, Holzinger D, Lainka E, Haas JP, Speth F, Kallinich T, et al. Practice and consensus-based strategies in diagnosing and managing systemic juvenile idiopathic arthritis in Germany. Pediatr Rheumatol. 2018, Jan, 22;16(1). https:\/\/doi.org\/10.1186\/s12969-018-0224-2.","DOI":"10.1186\/s12969-018-0224-2"},{"key":"1238_CR8","doi-asserted-by":"crossref","unstructured":"Lee JJY, Schneider R. Systemic juvenile idiopathic arthritis. In: Pediatric clinics of North America. Vol. 65. W.B. Saunders; 2018. p. 691\u2013709.","DOI":"10.1016\/j.pcl.2018.04.005"},{"issue":"6","key":"1238_CR9","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1053\/sarh.2000.5752","volume":"29","author":"S Trapani","year":"2000","unstructured":"Trapani S, Grisolia F, Simonini G, Battista Calabri G, Falcini F. Incidence of occult cancer in children presenting with musculoskeletal symptoms: a 10-year survey in a pediatric rheumatology unit. Semin Arthritis Rheumatism. 2000;29(6):348\u201359. https:\/\/doi.org\/10.1053\/sarh.2000.5752.","journal-title":"Semin Arthritis Rheumatism"},{"issue":"11","key":"1238_CR10","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/S1473-3099(17)30322-5","volume":"17","author":"FR Machado","year":"2017","unstructured":"Machado FR, Cavalcanti AB, Bozza FA, Ferreira EM, Angotti Carrara FS, Sousa JL, et al. The epidemiology of sepsis in Brazilian intensive care units (the sepsis PREvalence assessment database, SPREAD): an observational study. The Lancet Infect Dis. 2017, Nov, 1;17(11):1180\u201389. https:\/\/doi.org\/10.1016\/S1473-3099(17)30322-5.","journal-title":"The Lancet Infect Dis"},{"issue":"3","key":"1238_CR11","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/art.39332","volume":"68","author":"A Ravelli","year":"2016","unstructured":"Ravelli A, Minoia F, Dav\u00ec S, Horne A, Bovis F, Pistorio A, et al. 2016 Classification criteria for Macrophage activation syndrome Complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism\/American College of Rheumatology\/Paediatric Rheumatology International Trials Organisation collaborative initiative. Arthritis Rheumatol. 2016;68(3):566\u201376. https:\/\/doi.org\/10.1002\/art.39332. 2016 Mar 1.","journal-title":"Arthritis Rheumatol"},{"key":"1238_CR12","unstructured":"Scottish Paediatric & Adolescent Rheumatology network Initial diagnosis of Macrophage activation syndrome background."},{"key":"1238_CR13","doi-asserted-by":"publisher","unstructured":"He T. Pulmonary involvements in systemic juvenile arthritis. 2020, Available from: https:\/\/doi.org\/10.21203\/rs.3.rs-33776\/v1.","DOI":"10.21203\/rs.3.rs-33776\/v1"},{"issue":"11","key":"1238_CR14","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1002\/art.41073","volume":"71","author":"GS Schulert","year":"2019","unstructured":"Schulert GS, Yasin S, Carey B, Chalk C, Do T, Schapiro AH, et al. Systemic juvenile idiopathic arthritis\u2013associated lung disease: characterization and risk factors. Arthritis Rheumatol. 2019, Nov, 1;71(11):1943\u201354. https:\/\/doi.org\/10.1002\/art.41073.","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"1238_CR15","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1136\/annrheumdis-2019-216040","volume":"78","author":"VE Saper","year":"2019","unstructured":"Saper VE, Chen G, Deutsch GH, Guillerman RP, Birgmeier J, Jagadeesh K, et al. Emergent high fatality lung disease in systemic juvenile arthritis. Ann Rheumatic Dis. 2019;78(12):1722\u201331. https:\/\/doi.org\/10.1136\/annrheumdis-2019-216040.","journal-title":"Ann Rheumatic Dis"},{"key":"1238_CR16","doi-asserted-by":"crossref","unstructured":"Erkens R, Esteban Y, Towe C, Schulert G, Vastert S. Pathogenesis and treatment of refractory disease courses in systemic juvenile idiopathic arthritis: refractory arthritis, recurrent Macrophage activation syndrome and chronic lung disease. In: Rheumatic disease clinics of North America. Vol. 47. W.B. Saunders; 2021. p. 585\u2013606.","DOI":"10.1016\/j.rdc.2021.06.003"},{"issue":"5","key":"1238_CR17","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s40272-013-0038-0","volume":"15","author":"G Vannucci","year":"2013","unstructured":"Vannucci G, Cantarini L, Giani T, Marrani E, Moretti D, Pagnini I, et al. Glucocorticoids in the management of systemic juvenile idiopathic arthritis. Pediatr Drugs. 2013, Oct, 1;15(5):343\u201349. https:\/\/doi.org\/10.1007\/s40272-013-0038-0.","journal-title":"Pediatr Drugs"},{"key":"1238_CR18","doi-asserted-by":"publisher","unstructured":"Vastert SJ, Jamilloux Y, Quartier P, Ohlman S, Osterling Koskinen L, Kullenberg T, et al. Anakinra in children and adults with Still\u2019s disease. Rheumatol (U Kingd). 2019, Nov, 1;58(Supplement_6):vi9\u201322. https:\/\/doi.org\/10.1093\/rheumatology\/kez350.","DOI":"10.1093\/rheumatology\/kez350"},{"issue":"6","key":"1238_CR19","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/art.40884","volume":"71","author":"S Ringold","year":"2019","unstructured":"Ringold S, Angeles-Han ST, Beukelman T, Lovell D, Cuello CA, Becker ML, et al. 2019 American College of Rheumatology\/arthritis Foundation Guideline for the treatment of juvenile idiopathic arthritis: therapeutic Approaches for non-systemic polyarthritis, Sacroiliitis, and Enthesitis. Arthritis Rheumatol. 2019;71(6):846\u201363. https:\/\/doi.org\/10.1002\/art.40884. 2019 Jun 1.","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"1238_CR20","doi-asserted-by":"publisher","first-page":"416","DOI":"10.3899\/jrheum.180331","volume":"46","author":"B Saccomanno","year":"2019","unstructured":"Saccomanno B, Tibaldi J, Minoia F, Bagnasco F, Pistorio A, Guariento A, et al. Predictors of effectiveness of anakinra in systemic juvenile idiopathic arthritis. J Rheumatol. 2019;46(4):416\u201321. https:\/\/doi.org\/10.3899\/jrheum.180331.","journal-title":"J Rheumatol"},{"issue":"9","key":"1238_CR21","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1136\/ard.2010.145359","volume":"70","author":"Y Inaba","year":"2011","unstructured":"Inaba Y, Ozawa R, Imagawa T, Mori M, Hara Y, Miyamae T, et al. Radiographic improvement of damaged large joints in children with systemic juvenile idiopathic arthritis following tocilizumab treatment. Ann Rheumatic Dis. 2011;70(9):1693\u201395. https:\/\/doi.org\/10.1136\/ard.2010.145359.","journal-title":"Ann Rheumatic Dis"},{"issue":"4","key":"1238_CR22","doi-asserted-by":"publisher","first-page":"667","DOI":"10.3109\/s10165-012-0711-0","volume":"23","author":"Y Inaba","year":"2013","unstructured":"Inaba Y, Ozawa R, Aoki C, Imagawa T, Mori M, Hara R, et al. Radiologic analysis of the effect of tocilizumab on hands and large joints in children with systemic juvenile idiopathic arthritis. Mod Rheumatol. 2013, Jul;23(4):667\u201373. https:\/\/doi.org\/10.3109\/s10165-012-0711-0.","journal-title":"Mod Rheumatol"},{"issue":"7","key":"1238_CR23","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1002\/acr.21625","volume":"64","author":"EM Dewitt","year":"2012","unstructured":"Dewitt EM, Kimura Y, Beukelman T, Nigrovic PA, Onel K, Prahalad S, et al. Consensus treatment plans for new-onset systemic juvenile idiopathic arthritis. Arthritis Care Res (Hoboken). 2012, Jul;64(7):1001\u201310. https:\/\/doi.org\/10.1002\/acr.21625.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"10","key":"1238_CR24","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1093\/rheumatology\/kez157","volume":"58","author":"JF Swart","year":"2019","unstructured":"Swart JF, De Roock S, Nievelstein RAJ, Slaper-Cortenbach ICM, Boelens JJ, Wulffraat NM. Bone-marrow derived mesenchymal stromal cells infusion in therapy refractory juvenile idiopathic arthritis patients. Rheumatol (United Kingdom). 2019, Oct, 1;58(10):1812\u201317. https:\/\/doi.org\/10.1093\/rheumatology\/kez157.","journal-title":"Rheumatol (U Kingd)"},{"key":"1238_CR25","doi-asserted-by":"crossref","unstructured":"Bader-Meunier B, Hadchouel A, Berteloot L, Polivka L, B\u00e9ziat V, Casanova JL, et al. Effectiveness and safety of ruxolitinib for the treatment of refractory systemic idiopathic juvenile arthritis like associated with interstitial lung disease: a case report. In: Annals of the rheumatic diseases. Vol. 81. BMJ Publishing Group; 2022. p. E20.","DOI":"10.1136\/annrheumdis-2020-216983"},{"issue":"9","key":"1238_CR26","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1007\/s10067-011-1720-7","volume":"30","author":"EI Alexeeva","year":"2011","unstructured":"Alexeeva EI, Valieva SI, Bzarova TM, Semikina EL, Isaeva KB, Lisitsyn AO, et al. Efficacy and safety of repeat courses of rituximab treatment in patients with severe refractory juvenile idiopathic arthritis. Clin Rheumatol. 2011, Sep;30(9):1163\u201372. https:\/\/doi.org\/10.1007\/s10067-011-1720-7.","journal-title":"Clin Rheumatol"},{"issue":"1","key":"1238_CR27","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3899\/jrheum.100726","volume":"38","author":"JL Record","year":"2011","unstructured":"Record JL, Beukelman T, Cron RQ. Combination therapy of Abatacept and anakinra in children with refractory systemic juvenile idiopathic arthritis: a retrospective case series: table 1. J Rheumatol. 2011;38(1):180\u201381. https:\/\/doi.org\/10.3899\/jrheum.100726.","journal-title":"J Rheumatol"},{"issue":"5","key":"1238_CR28","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.jbspin.2006.12.004","volume":"74","author":"M Garc\u00eda-Carrasco","year":"2007","unstructured":"Garc\u00eda-Carrasco M, Fuentes-Alexandro S, Esc\u00e1rcega RO, Rojas-Rodriguez J, Escobar LE. Efficacy of thalidomide in systemic onset juvenile rheumatoid arthritis. Joint Bone Spine. 2007, Oct;74(5):500\u201303. https:\/\/doi.org\/10.1016\/j.jbspin.2006.12.004.","journal-title":"Joint Bone Spine"},{"key":"1238_CR29","volume-title":"Thalidomide for systemic onset juvenile idiopathic arthritis","author":"K Sathe","year":"2013","unstructured":"Sathe K, Khubchandani RP. Thalidomide for systemic onset juvenile idiopathic arthritis. Vol. 237. INDIAN PEDIATRICS; 2013."},{"issue":"7","key":"1238_CR30","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1007\/s12098-019-02912-9","volume":"86","author":"P Pal","year":"2019","unstructured":"Pal P, Giri PP, Sinha R. Cyclosporine in resistant systemic arthritis - a cheaper alternative to biologics. Indian J Pediatr. 2019;86(7):590\u201394. https:\/\/doi.org\/10.1007\/s12098-019-02912-9.","journal-title":"Indian J Pediatr"},{"key":"1238_CR31","volume-title":"Trial of intravenous pulse cyclophosphamide and methyleprednisolone in the treatment of severe systemic-onset juvenile rheumatoid arthritis","author":"CA Wallace","year":"1997","unstructured":"Wallace CA, Sherry DD. Trial of intravenous pulse cyclophosphamide and methyleprednisolone in the treatment of severe systemic-onset juvenile rheumatoid arthritis. Vol. 40. Arthritis & Rheumatism; 1997."},{"key":"1238_CR32","doi-asserted-by":"publisher","unstructured":"Boom V, Anton J, Lahdenne P, Quartier P, Ravelli A, Wulffraat NM, et al. Evidence-based diagnosis and treatment of macrophage activation syndrome in systemic juvenile idiopathic arthritis. Pediatr Rheumatol. 2015, Dec, 3;13(1). https:\/\/doi.org\/10.1186\/s12969-015-0055-3.","DOI":"10.1186\/s12969-015-0055-3"},{"key":"1238_CR33","first-page":"881","volume-title":"Macrophage activation syndrome in children with systemic onset juvenile idiopathic arthritis: clinical experience from northwest India","author":"S Singh","year":"2012","unstructured":"Singh S, Chandrakasan S, Ahluwalia J, Suri D, Rawat A, Ahmed N, et al. Macrophage activation syndrome in children with systemic onset juvenile idiopathic arthritis: clinical experience from northwest India. Vol. 32. Rheumatology International; 2012. p. 881\u201386."},{"key":"1238_CR34","unstructured":"Clinical commissioning policy statement: biologic therapies for the treatment of juvenile idiopathic arthritis (JIA)."},{"issue":"36","key":"1238_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta24360","volume":"24","author":"AP Jones","year":"2020","unstructured":"Jones AP, Clayton D, Nkhoma G, Sherratt FC, Peak M, Stones SR, et al. Different corticosteroid induction regimens in children and young people with juvenile idiopathic arthritis: the SIRJIA mixed-methods feasibility study. Health Technol Assess (Rockv). 2020;24(36):1\u2013152. https:\/\/doi.org\/10.3310\/hta24360.","journal-title":"Health Technol Assess (Rockv)"},{"issue":"7","key":"1238_CR36","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1002\/acr.21947","volume":"65","author":"C Papadopoulou","year":"2013","unstructured":"Papadopoulou C, Kostik M, Gonzalez-Fernandez MI, Bohm M, Nieto-Gonzalez JC, Pistorio A, et al. Delineating the role of multiple intraarticular corticosteroid injections in the management of juvenile idiopathic arthritis in the biologic era. Arthritis Care Res (Hoboken). 2013;65(7):1112\u201320. https:\/\/doi.org\/10.1002\/acr.21947.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"1238_CR37","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/art.39332","volume":"68","author":"A Ravelli","year":"2016","unstructured":"Ravelli A, Minoia F, Dav\u00ec S, Horne A, Bovis F, Pistorio A, et al. 2016 Classification criteria for Macrophage activation syndrome Complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism\/American College of Rheumatology\/Paediatric Rheumatology International Trials Organisation collaborative initiative. Arthritis Rheumatol. 2016;68(3):566\u201376. https:\/\/doi.org\/10.1002\/art.39332. 2016 Mar 1.","journal-title":"Arthritis Rheumatol"},{"key":"1238_CR38","first-page":"1839","volume-title":"Refractory systemic onset juvenile idiopathic arthritis: current challenges and future perspectives","author":"WG Ambler","year":"2022","unstructured":"Ambler WG, Nanda K, Onel KB, Shenoi S. Refractory systemic onset juvenile idiopathic arthritis: current challenges and future perspectives. Vol. 54. Annals of Medicine. Taylor and Francis Ltd; 2022. p. 1839\u201350."},{"key":"1238_CR39","doi-asserted-by":"publisher","unstructured":"Giancane G, Muratore V, Marzetti V, Quilis N, Benavente BS, Bagnasco F, et al. Disease activity and damage in juvenile idiopathic arthritis: methotrexate era versus biologic era. Arthritis Res Ther. 2019, Jul, 8;21(1). https:\/\/doi.org\/10.1186\/s13075-019-1950-7.","DOI":"10.1186\/s13075-019-1950-7"},{"issue":"7","key":"1238_CR40","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1002\/acr.23435","volume":"70","author":"G Simonini","year":"2018","unstructured":"Simonini G, Ferrara G, Pontikaki I, Scoccimarro E, Giani T, Taddio A, et al. Flares after Withdrawal of biologic therapies in juvenile idiopathic arthritis: clinical and laboratory correlates of remission duration. Arthritis Care Res (Hoboken). 2018, Jul, 1;70(7):1046\u201351. https:\/\/doi.org\/10.1002\/acr.23435.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"1238_CR41","doi-asserted-by":"publisher","unstructured":"Keskitalo PL, Kangas SM, Sard S, Pokka T, Glumoff V, Kulmala P, et al. Myeloid-related protein 8\/14 in plasma and serum in patients with new-onset juvenile idiopathic arthritis in real-world setting in a single center. Pediatr Rheumatol. 2022, Dec, 1;20(1). https:\/\/doi.org\/10.1186\/s12969-022-00701-x.","DOI":"10.1186\/s12969-022-00701-x"},{"key":"1238_CR42","first-page":"469","volume-title":"Treatment Withdrawal following remission in juvenile idiopathic arthritis: a systematic review of the literature","author":"O Halyabar","year":"2019","unstructured":"Halyabar O, Mehta J, Ringold S, Rumsey DG, Horton DB. Treatment Withdrawal following remission in juvenile idiopathic arthritis: a systematic review of the literature. Vol. 21. Pediatric Drugs. Adis; 2019. p. 469\u201392."},{"issue":"4","key":"1238_CR43","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/acr.24839","volume":"74","author":"KB Onel","year":"2022","unstructured":"Onel KB, Horton DB, Lovell DJ, Shenoi S, Cuello CA, Angeles-Han ST, et al. 2021 American College of Rheumatology Guideline for the treatment of juvenile idiopathic arthritis: recommendations for Nonpharmacologic therapies, medication Monitoring, Immunizations, and Imaging. Arthritis Care Res (Hoboken). 2022;74(4):505\u201320. https:\/\/doi.org\/10.1002\/acr.24839. 2022 Apr 1.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"1238_CR44","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fped.2023.1103763","volume":"11","author":"V Opoka-Winiarska","year":"2023","unstructured":"Opoka-Winiarska V, Lipinska J, Michalak A, Burzy\u0144ski J, K\u0105dzio\u0142ka O, Smolewska E. Safety of the COVID-19 vaccination in children with juvenile idiopathic arthritis\u2014A observational study from two pediatric rheumatology centres in Poland. Front Pediatr. 2023;11:11. https:\/\/doi.org\/10.3389\/fped.2023.1103763.","journal-title":"Front Pediatr"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-026-01238-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-026-01238-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-026-01238-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:37:14Z","timestamp":1792042634000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-026-01238-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,13]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1238"],"URL":"https:\/\/doi.org\/10.1186\/s12969-026-01238-z","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,13]]},"assertion":[{"value":"4 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval was not required for this guideline development as it did not involve primary data collection from human participants. Where applicable, the guideline development process adhered to established standards for ethical conduct in research and consensus development.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"73"}}